Evaluation of effectiveness and safety of «Apicold mint» nasal spray and «Apicold propo» nasal spray in complex treatment of acute adenoiditis in children

Yuriy V. Shevchuk, Marharyta Yu. Somushkina
{"title":"Evaluation of effectiveness and safety of «Apicold mint» nasal spray and «Apicold propo» nasal spray in complex treatment of acute adenoiditis in children","authors":"Yuriy V. Shevchuk, Marharyta Yu. Somushkina","doi":"10.37219/2528-8253-2021-6-52","DOIUrl":null,"url":null,"abstract":"Introduction: Adenoiditis affects 7 to 50% of children. Conservative treatment is preferred.\nObjective: Evaluation of the effectiveness and safety of «Apicold Mint» and «Apicold Propo» nasal spray in children with adenoiditis.\nMaterial and methods: A study of the action of «Apicold Mint» and «Apicold Propo» Nasal Spray (manufactured by APIPHARMA doo) in the treatment of adenoiditis. The clinical study involved 2570 children aged 4-17 years.\nResults and discussion: The use of «Apicold Mint» and «Apicold Propo» nasal spray helps reduce the symptoms of adenoiditis in the absence of side effects. In addition, the use of these drugs has reduced the need for intranasal and systemic antibiotics, intranasal glucocorticosteroids and decongestants, which is also positive in the treatment of patients with adenoiditis.\nConclusions: Appointment of «Apicold Mint» and «Apicold Propo» nasal spray in the complex therapy of adenoiditis contributes to a faster reduction of symptoms and increases the effectiveness of local and systemic drugs, in particular antibiotics.","PeriodicalId":447004,"journal":{"name":"OTORHINOLARYNGOLOGY No6(4) 2021","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"OTORHINOLARYNGOLOGY No6(4) 2021","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37219/2528-8253-2021-6-52","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Adenoiditis affects 7 to 50% of children. Conservative treatment is preferred. Objective: Evaluation of the effectiveness and safety of «Apicold Mint» and «Apicold Propo» nasal spray in children with adenoiditis. Material and methods: A study of the action of «Apicold Mint» and «Apicold Propo» Nasal Spray (manufactured by APIPHARMA doo) in the treatment of adenoiditis. The clinical study involved 2570 children aged 4-17 years. Results and discussion: The use of «Apicold Mint» and «Apicold Propo» nasal spray helps reduce the symptoms of adenoiditis in the absence of side effects. In addition, the use of these drugs has reduced the need for intranasal and systemic antibiotics, intranasal glucocorticosteroids and decongestants, which is also positive in the treatment of patients with adenoiditis. Conclusions: Appointment of «Apicold Mint» and «Apicold Propo» nasal spray in the complex therapy of adenoiditis contributes to a faster reduction of symptoms and increases the effectiveness of local and systemic drugs, in particular antibiotics.
“阿匹克薄荷”鼻喷雾剂和“阿匹克丙烯”鼻喷雾剂复合治疗儿童急性腺样体炎的有效性和安全性评价
简介:腺样体炎影响7 - 50%的儿童。首选保守治疗。目的:评价Apicold Mint和Apicold Propo鼻喷雾剂治疗儿童腺样体炎的有效性和安全性。材料和方法:研究了APIPHARMA公司生产的“Apicold Mint”和“Apicold Propo”鼻喷雾剂治疗腺样体炎的作用。该临床研究涉及2570名4-17岁的儿童。结果和讨论:使用“Apicold Mint”和“Apicold Propo”鼻喷雾剂有助于减轻腺样体炎的症状,没有副作用。此外,这些药物的使用减少了对鼻内和全身抗生素、鼻内糖皮质激素和减充血剂的需求,这对腺样体炎患者的治疗也是积极的。结论:在腺样体炎的综合治疗中使用“Apicold Mint”和“Apicold Propo”鼻喷雾剂有助于更快地减轻症状,并提高局部和全身药物,特别是抗生素的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信